Next Article in Journal
A Model-Informed Drug Development (MIDD) Approach for a Low Dose of Empagliflozin in Patients with Type 1 Diabetes
Next Article in Special Issue
BSA-Silver Nanoparticles: A Potential Multimodal Therapeutics for Conventional and Photothermal Treatment of Skin Cancer
Previous Article in Journal
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors
Previous Article in Special Issue
Pharmacokinetic Changes According to Single or Multiple Oral Administrations of Socheongryong-Tang to Rats: Presented as a Typical Example of Changes in the Pharmacokinetics Following Multiple Exposures to Herbal Medicines
 
 
Review

Article Versions Notes

Pharmaceutics 2021, 13(4), 484; https://doi.org/10.3390/pharmaceutics13040484
Action Date Notes Link
article xml file uploaded 2 April 2021 09:27 CEST Original file -
article xml uploaded. 2 April 2021 09:27 CEST Update -
article pdf uploaded. 2 April 2021 09:27 CEST Version of Record -
article html file updated 2 April 2021 09:28 CEST Original file -
article xml file uploaded 9 April 2021 07:51 CEST Update -
article xml uploaded. 9 April 2021 07:51 CEST Update -
article pdf uploaded. 9 April 2021 07:51 CEST Updated version of record -
article html file updated 9 April 2021 07:52 CEST Update -
article xml file uploaded 9 April 2021 07:55 CEST Update -
article xml uploaded. 9 April 2021 07:55 CEST Update https://www.mdpi.com/1999-4923/13/4/484/xml
article pdf uploaded. 9 April 2021 07:55 CEST Updated version of record https://www.mdpi.com/1999-4923/13/4/484/pdf
article html file updated 9 April 2021 07:56 CEST Update -
article html file updated 4 August 2021 02:06 CEST Update -
article html file updated 4 August 2021 02:18 CEST Update -
article html file updated 25 July 2022 10:29 CEST Update https://www.mdpi.com/1999-4923/13/4/484/html
Back to TopTop